as on February 2, 2026 at 11:42 am IST
Day's Low
Day's High
2.27%
Downside
2.27%
Upside
52 Week's Low
52 Week's High
9.14%
Downside
38.18%
Upside
as on February 2, 2026 at 11:42 am IST
Market Cap
₹10.10 Cr
Return on Equity (ROE)
8.77
PE Ratio (TTM)
0Return on capital employed (ROCE)
11.55
Beta (LTM)
0.69
P/B Ratio
3.11
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-845.45
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Unjha Formulations with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 10.10 | 26.3% | 0.00 | NA | 13 | |
| NA | 12.00 | -7.67% | 0.00 | NA | 51 | |
| NA | 130.72 | -0.41% | 0.74 | 9 | 96 | |
| NA | 90.12 | -0.08% | 0.00 | 2 | 44 | |
| NA | 37.83 | -11.38% | 0.00 | 1 | 124 |
Get share price movements and forecasts by analysts on Unjha Formulations.
Source: S&P Global Market Intelligence
Search interest for Unjha Formulations Ltd Stock has increased by 94% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:94% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Unjha Formulations.
Unjha Formulations Ltd’s net profit jumped 845.45% since last year same period to ₹0.82Cr in the Q2 2025-2026. On a quarterly growth basis, Unjha Formulations Ltd has generated 110.26% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, Unjha Formul. stock has moved up by 4.0%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 36.93% of holdings in Dec 2025 quarter
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 63.08% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 159.4% return, outperforming this stock by 115.3%
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 26.1% return, outperforming this stock by 42.6%
| Organisation | Unjha Formulations Ltd |
| Headquarters | Patan |
| Industry | Pharmaceuticals |
| CEO | Jashodaben S Patel |
| E-voting on shares | Click here to vote |
Unjha Formulations share price today stands at ₹22 as on . Unjha Formulations share today touched a day high of ₹22.5 and a low of ₹21.5.
Unjha Formulations touched a 52 week high of ₹30.4 and a 52 week low of ₹19.99. Unjha Formulations share price today i.e. is trending at ₹22, which is -27.63% down from its 52 week high and 10.06% up from its 52 week low.
Unjha Formulations market capitalisation is ₹10.10 Cr as on .
To buy Unjha Formulations shares, you need to follow these steps:
Unjha Formulations trading volume is 613.00 as on . This means that 613.00 shares of Unjha Formulations were bought and sold on the stock market during today's trading session.